During the past decade, CHU de Poitiers conducted 641 clinical trials. In the 10-year time frame, 641 clinical trials started and 68 clinical trials were completed, i.e. on average, 10.6% percent of trials that started reached the finish line to date. In the past 5 years, 332 clinical trials started and 47 clinical trials were completed. i.e. 14.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHU de Poitiers" #1 sponsor was "Poitiers University Hospital" with 171 trials, followed by "Nantes University Hospital" with 50 trials sponsored, "UNICANCER" with 24 trials sponsored, "Janssen Research & Development, LLC" with 23 trials sponsored and "University Hospital, Bordeaux" with 23 trials sponsored. Other sponsors include 585 different institutions and companies that sponsored additional 202 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU de Poitiers" #1 collaborator was "Ministry of Health, France" with 26 trials as a collaborator, "Poitiers University Hospital" with 13 trials as a collaborator, "Novartis" with 11 trials as a collaborator, "AstraZeneca" with 9 trials as a collaborator and "Roche Pharma AG" with 9 trials as a collaborator. Other collaborators include 480 different institutions and companies that were collaborators in the rest 334 trials.

According to Clinical.Site data, the most researched conditions in "CHU de Poitiers" are "Multiple Myeloma" (25 trials), "Breast Cancer" (14 trials), "Metastatic Colorectal Cancer" (11 trials), "Acute Myeloid Leukemia" (10 trials) and "Heart Failure" (10 trials). Many other conditions were trialed in "CHU de Poitiers" in a lesser frequency.

Most popular intervention types in "CHU de Poitiers" are "Drug" (447 trials), "Other" (176 trials), "Device" (106 trials), "Procedure" (83 trials) and "Biological" (28 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (69 trials), "Dexamethasone" (21 trials), "Gemcitabine" (15 trials), "Cyclophosphamide" (13 trials) and "Lenalidomide" (12 trials). Other intervention names were less common.

The vast majority of trials in "CHU de Poitiers" are 804 trials for "All" genders, 53 trials for "Female" genders and 24 trials for "Male" genders.

Currently, there are NaN active trials in "CHU de Poitiers". 15 are not yet recruiting, 251 are recruiting, 77 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 406 completed trials in CHU de Poitiers, 2 suspended trials, and 53 terminated clinical trials to date.

Out of the total trials that were conducted in CHU de Poitiers, 39 "Phase 1" clinical trials were conducted, 181 "Phase 2" clinical trials and 243 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 39 trials, and there were also 219 trials that are defined as “Not Applicable".

CHU de Poitiers has several departments that took part in Clinical trials: "Hopital De La Miletrie; Hematologie Et Oncologie Medicale" - 11 trials, "Chu La Miletrie; Gastro Enterologie Endoscopies" - 5 trials, "Medical intensive care unit" - 4 trials, "Chu La Miletrie;Nephrologie Transplantation" - 4 trials, "CHU Poitiers - Hôpital la Milétrie - service d'oncologie médicale" - 4 trials, "POITIERS - Hôpital La Milétrie - Hématologie Clinique" - 4 trials, "Chu La Miletrie; Oncologie Medicale" - 2 trials, "Chu La Miletrie; Radiotherapie" - 2 trials, "CHU La Milétrie - Oncology Radiotherapy" - 2 trials, "Virologie" - 2 trials